Literature DB >> 33969141

Investigation of the FSHR, CYP11, and INSR Mutations and Polymorphisms in Iranian Infertile Women with Polycystic Ovary Syndrome (PCOS).

Elaheh Seyed Abutorabi1, Batool Hossein Rashidi1, Shiva Irani2, Fedyeh Haghollahi1, Maryam Bagheri1.   

Abstract

BACKGROUND: Polycystic ovary syndrome (PCOS) is the most common cause of ovarian dysfunction associated with infertility, Oligomenorrhea or amenorrhea, hirsutism, acne, and obesity. A large body of evidence unraveled, three major groups of genes play critical roles in underlying PCOS molecular mechanism. The aim of this study is to investigate critical exonic variant of FSHR, CYP11, and INSR and determine the functionality of these mutations in Iranian patients with PCOS.
METHODS: In this case-control study, 130 patients with PCOS who referred to the Vali-e-Asr Hospital with infertility were included. DNA extracted from three ml of peripheral blood of the participants for DNA extraction. The PCR was conducted for each gene and the PCR product was genotyped by sequencing.
RESULTS: The data showed that there were two polymorphisms in INSR genes which did not change the protein sequences; these alterations can also be considered as a single nucleotide polymorphism (SNP). Moreover, any exonic variant has not been detected in CYP11B1. Whereas, two missense mutation have been detected in FSHR gene including p.Ala307Thr and p.Asn680Ser. It has been shown that the polymorphisms of the FSHR gene affect the hormone response in the ovaries. Our data demonstrated that the FSHR mutations frequencies were higher in the patients with PCOS rather than control people significantly.
CONCLUSION: These data showed that the polymorphisms of FSHR were significantly associated with PCOS in Iranian infertile women. Further studies with larger sample sizes are needed to be performed for explore the strength of the association.

Entities:  

Keywords:  CYP11; FSHR; INSR; Infertile; PCOS; Polymorphisms

Year:  2021        PMID: 33969141      PMCID: PMC8068450          DOI: 10.52547/rbmb.9.4.470

Source DB:  PubMed          Journal:  Rep Biochem Mol Biol        ISSN: 2322-3480


  32 in total

Review 1.  [Epidemiology and genetics of polycystic ovary syndrome: recent date].

Authors:  J-F Strauss
Journal:  J Gynecol Obstet Biol Reprod (Paris)       Date:  2003

2.  Follicle-stimulating hormone receptor gene polymorphisms are not associated with ovarian reserve markers.

Authors:  Lamiya Mohiyiddeen; William G Newman; Helen McBurney; Betselot Mulugeta; Stephen A Roberts; Luciano G Nardo
Journal:  Fertil Steril       Date:  2012-01-21       Impact factor: 7.329

3.  Fluoride Exposure, Follicle Stimulating Hormone Receptor Gene Polymorphism and Hypothalamus-pituitary-ovarian Axis Hormones in Chinese Women.

Authors:  Ming Xu Zhao; Guo Yu Zhou; Jing Yuan Zhu; Biao Gong; Jia Xiang Hou; Tong Zhou; Li Ju Duan; Zhong Ding; Liu Xin Cui; Yue Ba
Journal:  Biomed Environ Sci       Date:  2015-09       Impact factor: 3.118

4.  Two FSHR variants, haplotypes and meta-analysis in Chinese women with premature ovarian failure and polycystic ovary syndrome.

Authors:  Jing Du; Wenjing Zhang; Lingli Guo; Zhaofeng Zhang; Huijuan Shi; Jian Wang; Huiqin Zhang; Linghan Gao; Guoyin Feng; Lin He
Journal:  Mol Genet Metab       Date:  2010-03-27       Impact factor: 4.797

5.  The Ser680Asn polymorphism in the follicle-stimulating hormone receptor gene is associated with the ovarian response in controlled ovarian hyperstimulation.

Authors:  Xianliang Huang; Lu Li; Ling Hong; Weijin Zhou; Huijuan Shi; Huiqin Zhang; Zhaofeng Zhang; Xiaoxi Sun; Jing Du
Journal:  Clin Endocrinol (Oxf)       Date:  2014-10-03       Impact factor: 3.478

6.  FSH-receptor Ala307Thr polymorphism is associated to polycystic ovary syndrome and to a higher responsiveness to exogenous FSH in Italian women.

Authors:  Elisabetta Dolfin; Benedetta Guani; Cristina Lussiana; Caterina Mari; Gabriella Restagno; Alberto Revelli
Journal:  J Assist Reprod Genet       Date:  2011-07-27       Impact factor: 3.412

7.  Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation.

Authors:  Hermann M Behre; Robert R Greb; Andrea Mempel; Barbara Sonntag; Ludwig Kiesel; Petra Kaltwasser; Ewald Seliger; Friedrich Röpke; Jörg Gromoll; Eberhard Nieschlag; Manuela Simoni
Journal:  Pharmacogenet Genomics       Date:  2005-07       Impact factor: 2.089

8.  Genetics of polycystic ovary syndrome.

Authors:  N Prapas; A Karkanaki; I Prapas; I Kalogiannidis; I Katsikis; D Panidis
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

Review 9.  The genetics of polycystic ovary syndrome.

Authors:  Paula Amato; Joe Leigh Simpson
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2004-10       Impact factor: 5.237

Review 10.  Specificity of the cyclic adenosine 3',5'-monophosphate signal in granulosa cell function.

Authors:  Marco Conti
Journal:  Biol Reprod       Date:  2002-12       Impact factor: 4.285

View more
  3 in total

Review 1.  Metabolic and Molecular Mechanisms of Diet and Physical Exercise in the Management of Polycystic Ovarian Syndrome.

Authors:  Giorgia Scarfò; Simona Daniele; Jonathan Fusi; Marco Gesi; Claudia Martini; Ferdinando Franzoni; Vito Cela; Paolo Giovanni Artini
Journal:  Biomedicines       Date:  2022-06-02

Review 2.  A Review on CYP11A1, CYP17A1, and CYP19A1 Polymorphism Studies: Candidate Susceptibility Genes for Polycystic Ovary Syndrome (PCOS) and Infertility.

Authors:  Roozbeh Heidarzadehpilehrood; Maryam Pirhoushiaran; Rasoul Abdollahzadeh; Malina Binti Osman; Maryam Sakinah; Norshariza Nordin; Habibah Abdul Hamid
Journal:  Genes (Basel)       Date:  2022-02-05       Impact factor: 4.096

Review 3.  An update on polycystic ovary syndrome: A review of the current state of knowledge in diagnosis, genetic etiology, and emerging treatment options.

Authors:  Hiya Islam; Jaasia Masud; Yushe Nazrul Islam; Fahim Kabir Monjurul Haque
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.